Placenta
Volume 30, Supplement , Pages 55-65, March 2009

Gabor Than Award Lecture 2008: Pre-eclampsia – From Placental Oxidative Stress to Maternal Endothelial Dysfunction

  • T. Cindrova-Davies

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 01223 333 816; fax: +44 01223 333 840.

Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK

Accepted 17 November 2008. published online 05 January 2009.

Abstract 

Pre-eclampsia is the most important complication of human pregnancy worldwide and a major contributor to maternal and fetal morbidity and mortality. Strong evidence exists that generation of placental oxidative stress, secondary to deficient spiral artery remodelling, is a key intermediary event, triggering the secretion of a mixture of placental factors that culminate in an enhanced maternal inflammatory response. Reactive oxygen species (ROS) have been recognised as secondary messengers in intracellular signalling cascades. Experiments studying placental ischaemia-reperfusion in vitro or in vivo during labour provide strong evidence suggesting that oxidative stress and ROS production can activate downstream stress-signalling pathways, p38 and SAPK/JNK MAPK, and the pro-inflammatory NF-κB signalling pathway, culminating in the release of inflammatory mediators, apoptotic debris, anti-angiogenic factors and other mediators, which then stimulate a maternal inflammatory reaction that manifests in endothelial dysfunction and the symptoms of pre-eclampsia. Addition of anti-oxidants or blocking the stress or inflammatory pathways in vitro attenuates these effects and opens possibilities for therapeutic intervention.

Keywords: Oxidative stress, Signalling pathways, Pre-eclampsia, Inflammation, Endothelial dysfunction

 

PII: S0143-4004(08)00388-3

doi:10.1016/j.placenta.2008.11.020

Placenta
Volume 30, Supplement , Pages 55-65, March 2009